Proceedings of the National Academy of Sciences · 1994 · 218 citations · 32 references
Life SciencesImmunologyInfectious DiseasesGene DeliveryGene TherapyMolecular VirologyCytokine EngineeringCytokine-based TherapyInnate Immune Signaling PathwaysAdeno-associated Viral VectorsAdenoviral VectorsAdenovirus VectorsHomozygous DeletionPhenotypic RegulationReplication-incompetent VectorsTumor Necrosis Factor Inhibitor TherapyTumor Necrosis Factor Therapy
A chimeric protein capable of binding and neutralizing tumor necrosis factor (TNF) and lymphotoxin was expressed in mice transduced with a replication-incompetent adenoviral vector into which a TNF inhibitor gene had been engineered. Within 3 days following the injection of 10(9) infectious particles, the TNF inhibitor concentration exceeded 1 mg/ml of plasma; this level of expression was maintained for at least 4 weeks, and detectable TNF inhibitory activity was measured 6 weeks after injection of the recombinant virus. Introduction of the artificial gene produced a phenotypic effect comparable to homozygous deletion of the 55-kDa TNF receptor, in that animals were rendered highly susceptible to infection by Listeria monocytogenes, whereas control animals receiving a replication-incompetent virus coding for beta-galactosidase were capable of resisting Listeria challenge. Adenovirus-mediated transfer of a gene encoding a TNF inhibitor offers a practical means of imposing effective, long-term blockade of TNF activity in vivo for investigational and therapeutic purposes.
32
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Haider Raza, Annie John, Abderrahim Nemmar · Cellular Physiology and Biochemistry · 2013 · 47.3K citations · Full text
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Kevin J. Tracey, Yuman Fong, David Hesse et al. · Nature · 1987 · 2.5K citations